Olmesartan Medoxomil CAS:144689-63-4 Manufacturer Supplier

Olmesartan Medoxomil, is a new selective and competitive nonpeptide angiotensin II type 1 receptor antagonist and potently inhibits the Ang.ll-induced pressor responses. The drug competitively inhibited binding of [125I1]-All to AT1 receptors in bovine adrenal cortical membranes, but had no effect on binding to AT2 receptors in bovine cerebellar membranes. Olmesartan medoxomil was also shown to reduce blood pressure significantly more effectively than losartan and the ACE inhibitor captopril and as effectively as the pbloker atenolol.

Products Details

Application and Effect

Olmesartan medoxomil is an angiotensin II receptor antagonist used to treat high blood pressure. Olmesartan works by blocking the binding of angiotensin II to the AT1 receptors in vascular muscle. By blocking the binding rather than the synthesis of angiotensin II, olmesartan inhibits the negative regulatory feedback on renin secretion.Olmesartan medoxomil is a pro-drug that is de-esterified to the active metabolite, olmesartan. Olmesartan has a dual method of elimination, with about 60% eliminated by the liver and the remainder by the kidney. In situations of impaired renal or hepatic function, the alternative excretion pathway can compensate for the compromised one.

Product Sample

Product Packing:

Additional Information:

Composition C29H30N6O6
Assay 99%
Appearance White to beige powder
CAS No. 144689-63-4
Packing 25KG
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours